ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Rheumatology

Top Rheumatology Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL BROWN M.D.

Rheumatology

6,413

$984K

237
78 are 65+

72%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$153
Average prescription price

Avg: $169

JAMES BYRD M.D., PH.D.

Rheumatology

6,299

$1.38M

717
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$220
Average prescription price

Avg: $169

PETER MOHAI MD

Rheumatology

5,635

$553K

299
213 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $169

RICHARD JIMENEZ MD

Rheumatology

4,841

$860K

268
182 are 65+

28%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$178
Average prescription price

Avg: $169

JAMES NAKASHIMA MD

Rheumatology

4,513

$719K

434
299 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$159
Average prescription price

Avg: $169

RICHARD NEIMAN MD

Rheumatology

4,469

$1.21M

522
424 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$270
Average prescription price

Avg: $169

GEORGE KRICK MD

Rheumatology

4,421

$843K

455
352 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$191
Average prescription price

Avg: $169

JOHN YUEN M.D.

Rheumatology

3,831

$723K

326
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$189
Average prescription price

Avg: $169

SHAWN SLACK MD

Rheumatology

3,565

$626K

321
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$176
Average prescription price

Avg: $169

ANDREW SOHN MD

Rheumatology

3,263

$323K

361
278 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$99
Average prescription price

Avg: $169

KEVIN WELK MD

Rheumatology

3,235

$482K

348
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$149
Average prescription price

Avg: $169

JEFFREY CARLIN MD

Rheumatology

3,078

$524K

360
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$170
Average prescription price

Avg: $169

MARY WEMPLE M.D.

Rheumatology

2,722

$472K

197
122 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$173
Average prescription price

Avg: $169

DINA TITOVA MD

Rheumatology

2,709

$482K

229
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$178
Average prescription price

Avg: $169

VERLENE GAUTHIER M.D.

Rheumatology

2,696

$903K

303
247 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$335
Average prescription price

Avg: $169

ANDREW SOLOMON MD

Rheumatology

2,543

$275K

171
125 are 65+

36%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$108
Average prescription price

Avg: $169

ZHIQIAN WANG MD

Rheumatology

2,526

$379K

323
177 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$150
Average prescription price

Avg: $169

SEAN LASALLE MD

Rheumatology

2,491

$296K

317
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$119
Average prescription price

Avg: $169

THUC NGUYEN MD

Rheumatology

2,452

$402K

311
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$164
Average prescription price

Avg: $169

JULIE CARKIN MD

Rheumatology

2,414

$364K

195
150 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$151
Average prescription price

Avg: $169

CHRISTI KENYON MD

Rheumatology

2,408

$209K

151
112 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 8%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$87
Average prescription price

Avg: $169

KENT TA MD

Rheumatology

2,408

$374K

289
223 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$155
Average prescription price

Avg: $169

CATHERINE LEE MD

Rheumatology

2,396

$445K

191
110 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$186
Average prescription price

Avg: $169

JOHN BALDWIN MD

Rheumatology

2,287

$178K

253
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$78
Average prescription price

Avg: $169

SHERRY WU MD

Rheumatology

2,213

$590K

242
131 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$266
Average prescription price

Avg: $169

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank